ABVC earnings date and last-quarter result: P/E -10.27. Updated 2026-07-23.
ABVC BioPharma (ABVC) Research Hub
ABVC BioPharma (ABVC) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.05 USD (+0.96%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.27, market cap 0.02B. This hub links to the full technical, earnings and options research available for ABVC.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.05 USD (+0.96%) |
| 52-week range | 0.707 USD – 2.15 USD |
| Trend regime | Range |
| 14-day RSI | 60 (Bullish) |
| Trailing P/E | -10.27 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
Available research for ABVC
Covered Call on ABVC: how it works, illustrative setup around the real 1.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ABVC: how it works, illustrative setup around the real 1.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ABVC: how it works, illustrative setup around the real 1.05 USD price, max profit/loss, breakeven and when to use it. Educational.
ABVC technical analysis: range, last 1.05 USD, RSI 60, 52w range 0.707 USD–2.15 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ABVC in?
ABVC BioPharma (ABVC) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ABVC in an uptrend or downtrend?
As of 2026-10-26, ABVC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ABVC's trailing P/E ratio?
ABVC's trailing P/E is -10.27, with a market cap of 0.02B. See the earnings research page for full valuation detail.